What AI says about Onc.AI

Onc.AI is a privately held digital health company that aims to radically improve oncology decision making through artificial intelligence. Its Onclara platform uses real-world oncology data to train predictive and prognostic AI models; Onclara Evaluate supports Phase Ib/II trial decision-making and Onclara IO predicts responses and outcomes for metastatic lung cancer patients treated with immunotherapy. The company has FDA Breakthrough Device designation and validates its models on large real-world datasets, operating with a remote-first, collaborative team.